Pharmaceutical development of medicines for paediatric use
| Current effective version |
|
| Reference number | EMA/CHMP/QWP/805880/2012 Rev. 2 |
| Published | 31/07/2013 |
| Effective from | 15/02/2014 |
| Keywords | Pharmaceutical development, quality, child, paediatric formulation, paediatric investigation plan (PIP) |
| Description | This document provides guidance on the pharmaceutical development of medicinal products for children between birth and 18 years of age. |
Document history
|
Revision 2 Current version |
 Adopted guideline
|
In operation: 15/02/2014–present |
| Revision 1 |
Published: 31/07/2013 Published: 04/01/2013 |
|
| First version |
Published: 04/01/2013 Published: 23/06/2011 Published: 29/07/2008 |